Profil
Ingmar Hoerr was the founder of CureVac NV, where he served as the Chief Executive Officer & Member-Supervisory Board from 2000 to 2020.
Dr. Hoerr is also the founder of CureVac SE.
Dr. Hoerr obtained a doctorate degree from Eberhard Karls Universität Tübingen and an MBA from Donau-Universität Krems.
Postes actifs de Ingmar Hoerr
| Sociétés | Poste | Début |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Fondateur | 11/05/2010 |
Anciens postes connus de Ingmar Hoerr
| Sociétés | Poste | Fin |
|---|---|---|
| CUREVAC N.V. | Fondateur | 01/03/2020 |
Formation de Ingmar Hoerr
| Donau-Universität Krems | Masters Business Admin |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
